Screener
Ionis Pharmaceuticals IONS Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 2:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000874015-26-000177
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Accrued compensation | (80,187) | (43,039) |
| Accrued liabilities and other liabilities | 21,003 | 333 |
| Deferred contract revenue | (20,818) | (13,718) |
| Net cash used in operating activities | (792,819) | (150,775) |
| Investing activities: | ||
| Purchases of short-term investments | (192,755) | (311,068) |
| Proceeds from sale of short-term investments | 752,824 | 494,755 |
| Purchases of property, plant and equipment | (21,763) | (12,577) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's operating cash flow?
- Ionis Pharmaceuticals (IONS) reported operating cash flow of -$792.82M in Q1 2026.
- How has Ionis Pharmaceuticals's operating cash flow changed year-over-year?
- Ionis Pharmaceuticals's operating cash flow decreased by 425.8% year-over-year, from -$150.78M to -$792.82M.
- What is the long-term trend for Ionis Pharmaceuticals's operating cash flow?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's operating cash flow has grown at a 71.8% compound annual growth rate (CAGR), from $30.8M to -$268.58M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Ionis Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude